Cancer research: Horizon Europe deal delay is causing UK “brain drain,” researchers warn

The delay in securing a post-Brexit research funding deal between the UK and European Union has “damaged” the UK’s reputation and led to researchers leaving the country to take up more attractive offers, leaders in cancer research have warned.Access to Horizon Europe—a research and innovation funding programme with an £81bn budget—was agreed as part of the Brexit agreement, but ran into difficulty when the UK and EU were in dispute over the Northern Ireland protocol.1“We need Horizon Europe very badly,” said Julian Downward, head of the Oncogene Biology Laboratory at the Francis Crick Institute. “The current situation is damaging UK science every day. We are losing top junior faculty regularly who decide to move to EU countries so they can take up European Research Council grants.”While there have been suggestions that the deal could soon be finalised, the ongoing delays are continuing to impact the research community negatively, Cancer Research…
Read Original Article: Cancer research: Horizon Europe deal delay is causing UK “brain drain,” researchers warn »